What is he best known for?
The fields of study he is best known for:
His primary areas of study are Biochemistry, Lantibiotics, Stereochemistry, Amino acid and Biosynthesis.
The various areas that Wilfred A. van der Donk examines in his Lantibiotics study include Lanthionine, Peptide sequence and In vitro.
His Stereochemistry research includes themes of Radical SAM, Metabolic pathway and Fosmidomycin.
His studies in Amino acid integrate themes in fields like Native chemical ligation and Thioether.
His work deals with themes such as Tripeptide, Natural product, Threonine and Posttranslational modification, which intersect with Biosynthesis.
He interconnects Combinatorial chemistry, Cysteine and Signal peptide in the investigation of issues within Peptide.
His most cited work include:
- Protein Radicals in Enzyme Catalysis. (1082 citations)
- Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature (1048 citations)
- Biosynthesis and mode of action of lantibiotics. (594 citations)
What are the main themes of his work throughout his whole career to date?
Wilfred A. van der Donk mostly deals with Biochemistry, Stereochemistry, Peptide, Biosynthesis and Lantibiotics.
His study in Enzyme, Amino acid, Peptide sequence, Signal peptide and Mutant falls within the category of Biochemistry.
His Stereochemistry research is multidisciplinary, relying on both Phosphonate, Protein structure, Substrate and Active site.
In his study, which falls under the umbrella issue of Peptide, Genome is strongly linked to Computational biology.
His Biosynthesis research is multidisciplinary, incorporating perspectives in Tripeptide, Methylation, Methyltransferase, Serine and Natural product.
Wilfred A. van der Donk combines subjects such as Lanthionine, Lipid II and Escherichia coli with his study of Lantibiotics.
He most often published in these fields:
- Biochemistry (59.46%)
- Stereochemistry (59.91%)
- Peptide (34.91%)
What were the highlights of his more recent work (between 2015-2021)?
- Stereochemistry (59.91%)
- Biochemistry (59.46%)
- Biosynthesis (33.11%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Stereochemistry, Biochemistry, Biosynthesis, Peptide and Enzyme.
His work carried out in the field of Stereochemistry brings together such families of science as Amino acid, Alanine, Substrate, Catalysis and Transfer RNA.
His research combines Antimicrobial and Biochemistry.
His Peptide research incorporates elements of Lantibiotics, Peptide sequence, Genome and Computational biology.
His Lantibiotics study incorporates themes from Gene cluster and Thioether.
His Enzyme research integrates issues from Kinase and Dehydroalanine.
Between 2015 and 2021, his most popular works were:
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease (143 citations)
- Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes (140 citations)
- New Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-translationally Modified Peptide Natural Products (136 citations)
In his most recent research, the most cited papers focused on:
Wilfred A. van der Donk mainly focuses on Biochemistry, Biosynthesis, Peptide, Stereochemistry and Enzyme.
Wilfred A. van der Donk regularly ties together related areas like Synthetic biology in his Biochemistry studies.
His biological study spans a wide range of topics, including Lantibiotics, Genome, Escherichia coli, Natural product and Computational biology.
Wilfred A. van der Donk has included themes like Lanthionine, Gene cluster and Antimicrobial peptides in his Lantibiotics study.
The concepts of his Stereochemistry study are interwoven with issues in Kinamycin, Bond formation, Nitrous acid and Glutamic acid metabolism.
His study in Enzyme is interdisciplinary in nature, drawing from both Transfer RNA and Dehydroalanine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
